Vanguard Portfolio Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRWD
Vanguard Portfolio Management's IRWD Position: Q3 2026 in Review
Vanguard Portfolio Management reduced its Ironwood Pharmaceuticals (IRWD) stake by 8.2% in Q3 2026, selling an estimated $1.88M and leaving 5,063,802 shares worth $20.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1953.
Vanguard Portfolio Management first reported a position in IRWD in Q1 2026 and has held it in 3 quarters since. The position peaked at $23.5M in Q1 2026. 233 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.
- Vanguard Portfolio Management held 5,063,802 shares of Ironwood Pharmaceuticals worth $20.1M as of Q3 2026.
- Vanguard Portfolio Management sold 449,553 Ironwood Pharmaceuticals shares in Q3 2026, an estimated $1.88M.
- Ironwood Pharmaceuticals made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #1953 holding.
- Vanguard Portfolio Management first reported a position in Ironwood Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- Vanguard Portfolio Management's Ironwood Pharmaceuticals position peaked at $23.5M in Q1 2026.
- 233 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.
Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.